Exercise intervention during chemotherapy for pancreatic cancer: Changes in body composition and function
Abstract Background Patients with pancreatic cancer often lose weight during chemotherapy with associated changes in body composition. The goal of the present analysis was to describe changes in body composition in pancreatic cancer patients on an exercise regimen. The long‐term goal is to determine...
Main Authors: | Kathryn H. Schmitz, Robert D. Boutin, James P. Yoon, Melanie Potiaumpai, Leon Lenchik, Carissa M. White, Victor Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | JCSM Rapid Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/rco2.74 |
Similar Items
-
Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
by: A. A. Klunichenko, et al.
Published: (2020-07-01) -
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
by: In-Ho Kim, et al.
Published: (2021-01-01) -
Sarcopenia: Molecular pathways and potential benefits of exercise training
by: Mehdi Zargani, et al.
Published: (2021-12-01) -
Role of Exercise in Skeletal Muscle Atrophy: A Mechanistic Investigation
by: Dae Yun Seo, et al.
Published: (2020-08-01) -
Regulation of mitochondrial dynamic equilibrium by physical exercise in sarcopenia: A systematic review
by: Yu-Feng Long, et al.
Published: (2022-07-01)